Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | NMT1 | P30419 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | SMO | Q99835 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1807044 | 0.85 | CYP1A2 (0.36) | KDM4ECYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL1807386 | 0.80 | PDE4D (0.43) | KDM4EL3MBTL1SMO | |
| SCHEMBL1806019 | 0.78 | TRPV1 (0.36) | KDM4ECYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL1805952 | 0.76 | DRD1 (0.39) | NAAA | |
| SCHEMBL1807207 | 0.73 | ERN1 (0.34) | — | |
| SCHEMBL1803650 | 0.73 | MEN1 (0.37) | KDM4E | |
| SCHEMBL16775577 | 0.69 | NMT1 (0.53) | KDM4EL3MBTL1CHRNB2CHRNA4NMT1 | |
| SCHEMBL1807099 | 0.67 | ALDH1A1 (0.38) | L3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL1806557 | 0.67 | FAAH (0.38) | KDM4EL3MBTL1FAAH | |
| SCHEMBL16785295 | 0.66 | NMT1 (0.44) | KDM4EL3MBTL1FAAHCHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501703-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | Eli Lilly and Company (US) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011060035-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |